Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > Question: Once LABS has 4 or 5 approved drugs, can they
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(571)
•••
Comment by mdjbrownon Jun 19, 2024 10:24am
57 Views
Post# 36095828

RE:RE:RE:RE:Question: Once LABS has 4 or 5 approved drugs, can they

RE:RE:RE:RE:Question: Once LABS has 4 or 5 approved drugs, can they QC1, it would be nice if Medipharm would expand on the following statement they made recently and in particular the IND's.

"MediPharm has been referenced in FDA Investigational New Drug Applications, an Abbreviated New Drug Application and a Drug Master File."


Also, it would be helpful to know as a shareholder if Medipharm is in fact involved in any of the 20 late stage trials in the US referred to by Medipharm in Feb 2022

"and there are over 20 strong novel cannabinoid-based drugs currently in the late-stage research process."

 https://www.newswire.ca/news-releases/medipharm-labs-enters-united-states-pharmaceutical-market-with-submission-of-fda-dmf-830091598.html


We know they are involved in the LiBBY trials, but I dont believe that trial is late stage.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities